US 11505604
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 11505604 (Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer) held by PRECISION BIOLOGICS, INC. expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P